Food Additive Reform: Time to Repeal the Delaney Clause?
Update Magazine | February/March 2019
Soy Milk, Spilt Milk? FDA’s Next Free Speech Conundrum
Update Magazine | February/March 2019
The Legalization of Hemp
Update Magazine | February/March 2019
Canada 2018 Year in Review: Top 10 Food Regulatory and Legal Issues
Update Magazine | February/March 2019
Status Quo Maintained: FDA Reverses Course on Generic Product Labeling
Update Magazine | February/March 2019
Global Focus: Japan’s Regenerative Medicine Regulatory Pathways
Update Magazine | February/March 2019
No Longer Business as Usual: FDA Exceptionalism, Commercial Speech, and the First Amendment (Open Access) GalleryNo Longer Business as Usual: FDA Exceptionalism, Commercial Speech, and the First Amendment (Open Access)
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Food, Dietary Supplements, Cosmetics, Publications, Tobacco Products, Volume 73.4
No Longer Business as Usual: FDA Exceptionalism, Commercial Speech, and the First Amendment (Open Access)
Food and Drug Law Journal | Volume 73 | Number 4
Alternative Organic: Legal Issues in Marketing Uncertified Organic Products
Food and Drug Law Journal | Volume 73 | Number 4
The Evolving Regulatory Landscape for Clinical Trials in India
Food and Drug Law Journal | Volume 73 | Number 4
How Might Manufacturers of E-Cigarettes Get New Product and MRTP Orders from FDA More Quickly and Easily?
Food and Drug Law Journal | Volume 73 | Number 4
